Von Willebrand Factor (vWF) Antigen

The Von Willebrand Factor (vWF) Antigen Test is a specialized coagulation test used to measure the amount of Von Willebrand Factor (vWF) present in the blood. Von Willebrand Factor is a vital clotting protein that helps platelets adhere to damaged blood vessels and plays an important role in stabilizing Factor VIII, another essential clotting factor.

The test is primarily used to diagnose and evaluate Von Willebrand Disease (VWD), the most common inherited bleeding disorder worldwide. Individuals with reduced or abnormal Von Willebrand Factor may experience excessive bleeding because blood clot formation is impaired.

The vWF Antigen Test measures the quantity of Von Willebrand Factor in circulation but does not evaluate its functionality. Therefore, it is often performed together with other specialized coagulation tests such as:

• vWF Activity Assay (Ristocetin Cofactor Activity)
• Factor VIII Activity
• vWF Multimer Analysis
• Platelet Function Studies

Together, these tests help determine the presence, type, and severity of Von Willebrand Disease.

Benefits of the Test

• Measures Von Willebrand Factor levels accurately
• Helps diagnose Von Willebrand Disease
• Assists in evaluating bleeding tendencies
• Supports investigation of clotting abnormalities
• Helps classify bleeding disorders
• Guides treatment planning and monitoring

Why Doctors Recommend This Test

Doctors may recommend a vWF Antigen Test for:

• Frequent nosebleeds
• Easy bruising
• Heavy menstrual bleeding
• Excessive bleeding after surgery or dental procedures
• Family history of bleeding disorders
• Unexplained prolonged bleeding
• Suspected Von Willebrand Disease
• Comprehensive coagulation evaluation

The test helps identify deficiencies in a key protein required for normal blood clotting.

Preparation Before Test

The test requires:

• Peripheral venous blood sample (citrated plasma)

Preparation generally includes:

• Fasting is usually not required
• Inform your physician about medications affecting clotting
• Report recent illness, pregnancy, or hormone therapy
• Follow laboratory instructions for sample collection

Since vWF levels can fluctuate due to stress, infection, pregnancy, and inflammation, clinical context is important when interpreting results.

Normal Reporting Time

Results are generally available within 2 to 7 working days, depending on laboratory methodology and workflow.

Who Should Take This Test?

• Individuals with unexplained bleeding
• Patients with suspected Von Willebrand Disease
• Individuals with heavy menstrual bleeding
• Patients with abnormal coagulation profiles
• Individuals with a family history of bleeding disorders
• Patients undergoing hematology evaluation

The test is an important component of comprehensive bleeding disorder assessment.

Clinical Significance

Low vWF Antigen Levels may be associated with:

• Von Willebrand Disease Type 1
• Von Willebrand Disease Type 3
• Certain Acquired Bleeding Disorders
• Reduced Clotting Function

Normal or Elevated vWF Levels may occur in:

• Healthy individuals
• Pregnancy
• Stress
• Infections
• Inflammatory Conditions

Because vWF is an acute-phase reactant, elevated levels do not always indicate normal clotting function.

Important Note

The vWF Antigen Test measures the amount of Von Willebrand Factor but does not assess how well it functions. Therefore, results should always be interpreted alongside vWF activity tests, Factor VIII levels, bleeding history, family history, and clinical findings.